Tiopronin-induced myasthenia.
Cherasse
A
A
Maillefert
J F
JF
Henlin
J L
JL
Chassard
D
D
Tavernier
C
C
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000139:chemically induced*; D009388:Neostigmine / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D008625:Tiopronin / Q000009:adverse effects*
D010277:Parasympathomimetics; D009388:Neostigmine; D008625:Tiopronin; D011729:Pyridostigmine Bromide; D011241:Prednisone